Flavio Cadegiani

1.8k total citations
45 papers, 828 citations indexed

About

Flavio Cadegiani is a scholar working on Infectious Diseases, Rehabilitation and Orthopedics and Sports Medicine. According to data from OpenAlex, Flavio Cadegiani has authored 45 papers receiving a total of 828 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Infectious Diseases, 15 papers in Rehabilitation and 14 papers in Orthopedics and Sports Medicine. Recurrent topics in Flavio Cadegiani's work include Exercise and Physiological Responses (15 papers), Sports Performance and Training (14 papers) and COVID-19 Clinical Research Studies (12 papers). Flavio Cadegiani is often cited by papers focused on Exercise and Physiological Responses (15 papers), Sports Performance and Training (14 papers) and COVID-19 Clinical Research Studies (12 papers). Flavio Cadegiani collaborates with scholars based in Brazil, United States and Australia. Flavio Cadegiani's co-authors include Cláudio E. Kater, Andy Goren, Carlos Gustavo Wambier, John McCoy, Ricardo Ariel Zimerman, Antonellá Tosti, Jerry Shapiro, Sergio Vañó‐Galván, Scott C. Forbes and Heitor O. Santos and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Sports Sciences and Frontiers in Endocrinology.

In The Last Decade

Flavio Cadegiani

45 papers receiving 786 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Flavio Cadegiani Brazil 19 235 229 211 120 99 45 828
Jonathon W. Senefeld United States 22 333 1.4× 427 1.9× 102 0.5× 145 1.2× 160 1.6× 83 1.3k
Sarah E. Baker United States 20 122 0.5× 231 1.0× 63 0.3× 144 1.2× 244 2.5× 86 1.2k
Marco Gervasi Italy 16 29 0.1× 164 0.7× 97 0.5× 109 0.9× 259 2.6× 49 886
Solange Marta Franzói de Moraes Brazil 18 30 0.1× 455 2.0× 139 0.7× 105 0.9× 289 2.9× 60 1.0k
Rhys Thatcher United Kingdom 15 39 0.2× 262 1.1× 160 0.8× 152 1.3× 235 2.4× 40 856
Zahra Alizadeh Iran 18 36 0.2× 63 0.3× 56 0.3× 40 0.3× 335 3.4× 71 1.1k
Paulo Moreira Silva Dantas Brazil 15 29 0.1× 302 1.3× 86 0.4× 65 0.5× 161 1.6× 116 803
Gregory Cloutier United States 13 114 0.5× 102 0.4× 77 0.4× 309 2.6× 435 4.4× 26 881
M. Hesselink Netherlands 20 34 0.1× 346 1.5× 114 0.5× 117 1.0× 256 2.6× 29 1.7k
Tadeusz Ambroży Poland 19 13 0.1× 397 1.7× 53 0.3× 41 0.3× 105 1.1× 128 936

Countries citing papers authored by Flavio Cadegiani

Since Specialization
Citations

This map shows the geographic impact of Flavio Cadegiani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Flavio Cadegiani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Flavio Cadegiani more than expected).

Fields of papers citing papers by Flavio Cadegiani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Flavio Cadegiani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Flavio Cadegiani. The network helps show where Flavio Cadegiani may publish in the future.

Co-authorship network of co-authors of Flavio Cadegiani

This figure shows the co-authorship network connecting the top 25 collaborators of Flavio Cadegiani. A scholar is included among the top collaborators of Flavio Cadegiani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Flavio Cadegiani. Flavio Cadegiani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Kory, Pierre, G. Umberto Meduri, José Iglesias, et al.. (2022). “MATH+” Multi-Modal Hospital Treatment Protocol for COVID-19 Infection: Clinical and Scientific Rationale. Journal of Clinical Medicine Research. 14(2). 53–79. 4 indexed citations
4.
Zimerman, Ricardo Ariel, Patrícia Aline Gröhs Ferrareze, Flavio Cadegiani, et al.. (2022). Comparative Genomics and Characterization of SARS-CoV-2 P.1 (Gamma) Variant of Concern From Amazonas, Brazil. Frontiers in Medicine. 9. 806611–806611. 14 indexed citations
5.
Santos, Heitor O., Flavio Cadegiani, & Scott C. Forbes. (2022). Nonpharmacological Interventions for the Management of Testosterone and Sperm Parameters: A Scoping Review. Clinical Therapeutics. 44(8). 1129–1149. 14 indexed citations
6.
Zheng, Kai, et al.. (2021). SARS-CoV-2 infection in patients with thyroid disease: a cross-sectional study. PubMed. 6. 7–7. 8 indexed citations
8.
Zimerman, Ricardo Ariel, Flavio Cadegiani, Rute Alves Pereira e Costa, Andy Goren, & Bruno Campello de Souza. (2021). Stay-At-Home Orders Are Associated With Emergence of Novel SARS-CoV-2 Variants. Cureus. 13(3). e13819–e13819. 5 indexed citations
10.
Cadegiani, Flavio, Ricardo Ariel Zimerman, Bruno Campello de Souza, et al.. (2021). The AndroCoV Clinical Scoring for COVID-19 Diagnosis: A Prompt, Feasible, Costless, and Highly Sensitive Diagnostic Tool for COVID-19 Based on a 1757-Patient Cohort. Cureus. 13(1). e12565–e12565. 7 indexed citations
12.
McCoy, John, Flavio Cadegiani, Carlos Gustavo Wambier, et al.. (2020). 5‐alpha‐reductase inhibitors are associated with reduced frequency of COVID‐19 symptoms in males with androgenetic alopecia. Journal of the European Academy of Dermatology and Venereology. 35(4). e243–e246. 27 indexed citations
13.
Cadegiani, Flavio, Andy Goren, & Carlos Gustavo Wambier. (2020). Spironolactone may provide protection from SARS-CoV-2: Targeting androgens, angiotensin converting enzyme 2 (ACE2), and renin-angiotensin-aldosterone system (RAAS). Medical Hypotheses. 143. 110112–110112. 33 indexed citations
14.
Cadegiani, Flavio & Cláudio E. Kater. (2020). Eating, Sleep, and Social Patterns as Independent Predictors of Clinical, Metabolic, and Biochemical Behaviors Among Elite Male Athletes: The EROS-PREDICTORS Study. Frontiers in Endocrinology. 11. 414–414. 8 indexed citations
15.
Cadegiani, Flavio & Cláudio E. Kater. (2019). Inter-correlations Among Clinical, Metabolic, and Biochemical Parameters and Their Predictive Value in Healthy and Overtrained Male Athletes: The EROS-CORRELATIONS Study. Frontiers in Endocrinology. 10. 858–858. 11 indexed citations
16.
Cadegiani, Flavio & Cláudio E. Kater. (2019). Novel causes and consequences of overtraining syndrome: the EROS-DISRUPTORS study. BMC Sports Science Medicine and Rehabilitation. 11(1). 21–21. 28 indexed citations
17.
Cadegiani, Flavio & Cláudio E. Kater. (2017). Hormonal response to a non-exercise stress test in athletes with overtraining syndrome: results from the Endocrine and metabolic Responses on Overtraining Syndrome (EROS) — EROS-STRESS. Journal of science and medicine in sport. 21(7). 648–653. 22 indexed citations
19.
Cadegiani, Flavio, et al.. (2016). Acarbose promotes remission of both early and late dumping syndromes in post-bariatric patients. Diabetes Metabolic Syndrome and Obesity. Volume 9. 443–446. 21 indexed citations
20.
Cadegiani, Flavio & Cláudio E. Kater. (2016). Adrenal fatigue does not exist: a systematic review. BMC Endocrine Disorders. 16(1). 48–48. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026